GO:0042813 Wnt receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042813 Wnt receptor activity is a molecular function defined as combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
• Wnt receptor activity is mediated by Frizzled (FZD) family receptors and co-receptors such as LRP5/LRP6, and can also involve ROR-family receptor tyrosine kinases.
• Wnt receptor engagement can activate canonical beta-catenin-dependent signaling and non-canonical pathways simultaneously in the same cell.
• Alternative Wnt signaling through receptors can activate YAP/TAZ transcriptional regulators, linking Wnt receptor activity to Hippo pathway control.
• WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth, showing context-dependent tumor-suppressive roles.
• Wnt receptor activity is implicated in cancer, lung physiology and pathology, bone mass regulation, and metabolic signaling, making it a key target for functional genomics and CRISPR modeling.
Description
Wnt receptor activity (GO:0042813) is a molecular function that enables a cell to bind a Wnt protein and transmit a signal across the plasma membrane to initiate a change in cell activity. This activity is central to metazoan development, tissue homeostasis, and regeneration, and its dysregulation is linked to cancer, fibrosis, and metabolic disease. The receptors that carry this activity include the Frizzled (FZD) family of seven-transmembrane proteins and co-receptors such as LRP5/LRP6, as well as ROR-family receptor tyrosine kinases that can bind Wnt ligands and activate downstream cascades. Mechanistically, Wnt receptor activity is not a single linear pathway. Canonical and non-canonical Wnt signaling can be simultaneously activated by Wnts in colon cancer cells, indicating that receptor engagement can branch into beta-catenin-dependent and beta-catenin-independent outputs. In addition, alternative Wnt signaling can activate YAP/TAZ, connecting Wnt receptor activity to mechanotransduction and Hippo pathway regulation. WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth, illustrating that Wnt receptor activity can have context-dependent tumor-suppressive functions. For researchers, GO:0042813 provides a precise functional annotation for genes and proteins that directly bind Wnt ligands and initiate transmembrane signaling. Understanding this activity is essential for interpreting CRISPR knockout, point-mutation, knock-in, and overexpression experiments, because loss of Wnt receptor activity can rewire multiple downstream transcriptional programs, including beta-catenin, YAP/TAZ, and Hippo outputs. This article summarizes the definition, mechanism, key genes, disease links, and experimental methods for studying Wnt receptor activity, with a focus on publication-ready, citation-backed content.
Wnt receptor activity At A Glance
| GO ID | GO:0042813 |
|---|---|
| GO term | Wnt receptor activity |
| Ontology | molecular_function |
| Synonym | frizzled-2 receptor activity; frizzled receptor activity; Wnt-activated receptor activity |
| Definition | Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
| Major function | Binding Wnt ligands and initiating transmembrane signaling that changes cell activity. |
| Representative receptors | Frizzled (FZD) family, LRP5/LRP6 co-receptors, ROR-family receptor tyrosine kinases. |
| Downstream outputs | Canonical beta-catenin signaling, non-canonical pathways, YAP/TAZ activation, Hippo pathway modulation. |
| Disease relevance | Cancer, lung pathology, bone mass regulation, metabolic signaling. |
What Is GO:0042813?
In the Gene Ontology, Wnt receptor activity (GO:0042813) is defined as combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity. This is a molecular function term, meaning it describes what a gene product does at the molecular level rather than a whole biological process or cellular location. Synonyms include frizzled-2 receptor activity, frizzled receptor activity, and Wnt-activated receptor activity. The activity requires ligand binding, receptor activation, and signal transduction across the membrane, and it is typically associated with Frizzled receptors and their co-receptors.
Why Is Wnt receptor activity Important in Cell Biology?
Wnt receptor activity is important because it sits at the top of a signaling hierarchy that controls cell proliferation, differentiation, polarity, and survival. Because the same receptor can engage canonical and non-canonical outputs simultaneously, the activity is a key node for understanding how cells interpret Wnt gradients and how tumors hijack these signals. It is also a therapeutic target: modulating Wnt receptor activity can affect cancer cell growth, lung remodeling, bone mass, and metabolic responses. For functional genomics, GO:0042813 provides a precise annotation to design and interpret CRISPR screens and validation experiments.
• Wnt receptor activity is required for embryonic development and tissue homeostasis, and its dysregulation contributes to cancer and fibrosis.
• Canonical and non-canonical Wnt signaling can be simultaneously activated by Wnts in colon cancer cells, making receptor activity a branching point for multiple outputs.
• Alternative Wnt signaling through receptors can activate YAP/TAZ, linking Wnt receptor activity to Hippo pathway and mechanotransduction.
• WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth, showing tumor-suppressive potential.
• Wnt receptor signaling is implicated in lung physiology and pathology, including airway remodeling and lung cancer.
• Exercise increases bone mass via lactate/Gpr81 signaling, and Wnt receptor activity is part of the broader bone mass regulatory network.
• SIRT1 mediates antagonism of the Wnt/beta-catenin pathway by vitamin D in colon carcinoma cells, showing cross-talk with metabolic regulators.
• Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens, affecting receptor engagement.
• ROR-family receptor tyrosine kinases are alternative Wnt receptors with roles in development and disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of Wnt receptor activity in disease contexts.
Wnt receptor activity: mechanism, components, and regulation
Ligand recognition and receptor engagement
In simple terms: Wnt proteins act like keys that fit into receptor locks on the cell surface.
Wnt receptor activity begins when a Wnt ligand binds a Frizzled (FZD) receptor or a co-receptor complex. Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens, which determines whether Wnt ligands reach their receptors. In colon cancer cells, Wnts can simultaneously activate canonical and non-canonical signaling, indicating that receptor engagement is not restricted to a single downstream branch. ROR-family receptor tyrosine kinases can also bind Wnts and function as alternative receptors.
Transmembrane signal initiation
In simple terms: Once the key is in the lock, the receptor changes shape and sends a signal inside the cell.
Upon ligand binding, the receptor transmits the signal across the plasma membrane to initiate a change in cell activity. This step often involves conformational changes and recruitment of intracellular adaptors. Alternative Wnt signaling can activate YAP/TAZ, showing that transmembrane initiation can feed into Hippo pathway components. WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth, demonstrating that receptor-proximal events can have distinct outputs depending on the receptor and ligand.
Canonical and non-canonical branching
In simple terms: The same receptor can send signals down more than one road at the same time.
Wnt receptor activity can branch into canonical beta-catenin-dependent signaling and non-canonical pathways. In colon cancer cells, canonical and non-canonical Wnt signaling are simultaneously activated by Wnts, indicating that receptor activity can drive multiple transcriptional and cytoskeletal programs in parallel. SIRT1 mediates the antagonism of the Wnt/beta-catenin pathway by vitamin D in colon carcinoma cells, showing that canonical output can be modulated by metabolic regulators.
Cross-talk with Hippo and YAP/TAZ
In simple terms: Wnt signals can talk to other growth-control pathways inside the cell.
Alternative Wnt signaling activates YAP/TAZ, linking Wnt receptor activity to Hippo pathway effectors. WNT5a signaling through ROR2 activates the Hippo pathway to suppress YAP1 activity and tumor growth, indicating that Wnt receptor activity can either promote or restrain YAP1 depending on context. This cross-talk is important for interpreting CRISPR phenotypes, because loss of a Wnt receptor may alter both beta-catenin and YAP/TAZ outputs.
Regulation by extracellular carriers and metabolic signals
In simple terms: How much Wnt reaches the receptor, and the cell's metabolic state, can tune the signal.
Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens, which directly affects receptor engagement. Metabolic and nutritional signals can also modulate Wnt output; for example, SIRT1 mediates the antagonism of Wnt/beta-catenin by vitamin D in colon carcinoma cells. Exercise increases bone mass via lactate/Gpr81 signaling, and Wnt receptor activity is part of the broader bone mass regulatory network.
Key Genes Involved in GO:0042813 Wnt receptor activity
The following genes and proteins are directly or functionally associated with Wnt receptor activity (GO:0042813), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FZD1 | Frizzled receptor that binds Wnt ligands and initiates signaling | Core receptor for Wnt receptor activity; knockout and overexpression models test ligand-dependent outputs. |
| FZD2 | Frizzled receptor; synonym frizzled-2 receptor activity | Directly linked to GO:0042813 synonym; useful for receptor-specific CRISPR studies. |
| FZD4 | Frizzled receptor involved in development and vascular biology | Candidate for knock-in reporters and point-mutation studies. |
| FZD5 | Frizzled receptor that can activate canonical and non-canonical pathways | Model for branching Wnt outputs in cancer cells. |
| FZD7 | Frizzled receptor frequently upregulated in cancer | Target for knockout and overexpression in colon cancer models. |
| LRP5 | Wnt co-receptor that enhances canonical signaling | Knockout models test co-receptor contribution to Wnt receptor activity. |
| LRP6 | Wnt co-receptor required for canonical beta-catenin activation | Point-mutation and knock-in models dissect co-receptor function. |
| ROR1 | ROR-family receptor tyrosine kinase that binds Wnt ligands | Alternative Wnt receptor; knockout models test non-canonical outputs. |
| ROR2 | ROR-family receptor tyrosine kinase; WNT5a receptor | WNT5a-ROR2 activates Hippo pathway to suppress YAP1. |
| WNT3A | Wnt ligand that activates canonical signaling | Used to stimulate Wnt receptor activity in cell-based assays. |
| WNT5A | Wnt ligand that activates non-canonical signaling | Ligand for ROR2 and other receptors; key for non-canonical studies. |
| CTNNB1 | Beta-catenin; downstream effector of canonical Wnt signaling | Readout of canonical Wnt receptor activity; knockout and knock-in models. |
| YAP1 | Hippo pathway effector activated by alternative Wnt signaling | Readout of non-canonical Wnt receptor activity. |
| SIRT1 | Deacetylase that antagonizes Wnt/beta-catenin in colon carcinoma | Modulator of canonical output; knockout models test cross-talk. |
| GPR81 | Lactate receptor linked to exercise-induced bone mass | Metabolic context for Wnt-related bone regulation. |
| VDR | Vitamin D receptor that antagonizes Wnt/beta-catenin via SIRT1 | Knockout and overexpression models test vitamin D-Wnt cross-talk. |
How Is Wnt receptor activity Regulated?
Wnt receptor activity is regulated at multiple levels. Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens, which determines ligand availability at the receptor. At the receptor level, co-receptors such as LRP5/LRP6 and ROR-family kinases modulate signaling output. Downstream, SIRT1 mediates the antagonism of the Wnt/beta-catenin pathway by vitamin D in colon carcinoma cells, showing metabolic and nuclear receptor control of canonical output. Alternative Wnt signaling can activate YAP/TAZ, and WNT5a-ROR2 signaling can activate the Hippo pathway to suppress YAP1, indicating that receptor activity is embedded in a network of growth-control pathways.
Wnt receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTNNB1 | Colon cancer; canonical Wnt output | Knockout and point-mutation models in colon cancer cell lines. |
| ROR2 | Tumor growth suppression via Hippo/YAP1 | Knockout and overexpression models to test WNT5a-ROR2 signaling. |
| SIRT1 | Colon carcinoma; vitamin D antagonism of Wnt/beta-catenin | Knockout and knock-in models to dissect SIRT1-dependent regulation. |
| FZD7 | Cancer; receptor-level Wnt activation | Knockout and overexpression in cancer cell lines. |
| GPR81 | Bone mass regulation by exercise/lactate | Knockout models to test metabolic control of bone mass. |
Wnt receptor activity in cancer
Wnt receptor activity is frequently dysregulated in cancer. In colon cancer cells, canonical and non-canonical Wnt signaling are simultaneously activated by Wnts, suggesting that receptor activity can drive multiple oncogenic programs at once. SIRT1 mediates the antagonism of the Wnt/beta-catenin pathway by vitamin D in colon carcinoma cells, highlighting a potential therapeutic axis. WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth, showing that some Wnt receptor outputs are tumor-suppressive.
Wnt receptor activity in lung physiology and pathology
WNT receptor signalling is implicated in lung physiology and pathology, including airway remodeling and lung cancer. Because Wnt receptor activity can branch into canonical and non-canonical outputs, lung disease models may require receptor-specific perturbations to dissect which branch drives pathology.
Wnt receptor activity in bone and metabolic regulation
Exercise increases bone mass via lactate/Gpr81 signaling, and Wnt receptor activity is part of the broader bone mass regulatory network. Metabolic signals such as vitamin D can antagonize Wnt/beta-catenin via SIRT1, linking Wnt receptor activity to metabolic control. These findings suggest that Wnt receptor activity is a node where mechanical, metabolic, and nutritional cues converge.
From Wnt receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a Frizzled receptor reduce Wnt receptor activity? | CRISPR knockout of FZD gene in a Wnt-responsive cell line. |
| Does a point mutation in LRP6 alter canonical Wnt output? | Point-mutation knock-in of LRP6 in cancer or stem cell models. |
| Can a tagged Wnt receptor be used to monitor trafficking? | Knock-in of an epitope tag at the endogenous FZD locus. |
| Does overexpression of WNT5A activate non-canonical signaling? | Overexpression of WNT5A in cells with ROR2 expression. |
| Does SIRT1 mediate vitamin D antagonism of Wnt/beta-catenin? | SIRT1 knockout and overexpression in colon carcinoma cells. |
| Does alternative Wnt signaling activate YAP/TAZ? | Overexpression or knockout of Wnt receptors followed by YAP/TAZ reporter assays. |
How to Study the Wnt receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Luciferase reporter assay | Canonical Wnt/beta-catenin transcriptional output | Testing Wnt receptor activity after ligand stimulation. |
| CRISPR knockout | Requirement of a receptor gene for Wnt signaling | Loss-of-function screens for Wnt receptor components. |
| Point-mutation knock-in | Function of specific receptor residues | Dissecting ligand-binding or signaling motifs. |
| Co-immunoprecipitation | Protein-protein interactions at the receptor | Identifying receptor complexes and adaptors. |
| Live-cell imaging | Receptor trafficking and signal dynamics | Monitoring tagged receptors at endogenous loci. |
| YAP/TAZ reporter assay | Non-canonical Wnt output | Testing alternative Wnt signaling. |
| RNA-seq | Transcriptional changes downstream of receptor activity | Global profiling of Wnt receptor-dependent programs. |
| Proteomics | Protein abundance and post-translational changes | Mapping signaling networks downstream of Wnt receptors. |
Transcriptional reporter assays
Wnt receptor activity can be measured using beta-catenin-responsive luciferase reporters. In colon cancer cells, canonical and non-canonical Wnt signaling are simultaneously activated by Wnts, so combining canonical reporters with non-canonical readouts provides a more complete picture. SIRT1-mediated antagonism of Wnt/beta-catenin by vitamin D can be quantified with such reporters.
CRISPR knockout and point-mutation screens
CRISPR knockout of FZD, LRP5/6, or ROR genes can test which receptors are required for Wnt receptor activity. Point-mutation knock-in can dissect specific residues required for ligand binding or signal transduction. These approaches are essential for causal inference in Wnt receptor biology.
Protein interaction and proximity assays
Co-immunoprecipitation, proximity labeling, and split-protein assays can identify receptor-proximal components. ROR-family receptor tyrosine kinases are alternative Wnt receptors, and their interactions can be mapped with these methods. Extracellular carriers that control WNT morphogen delivery can also be studied with biochemical assays.
Imaging and live-cell assays
Live-cell imaging of tagged receptors can reveal receptor internalization, trafficking, and signal duration. Knock-in of fluorescent tags at endogenous FZD or ROR loci enables physiological expression levels. These methods complement endpoint transcriptional readouts.
How CRISPR Can Be Used to Study GO:0042813 Wnt receptor activity
Knockout
CRISPR knockout of FZD, LRP5/6, or ROR genes is used to test whether a specific receptor is required for Wnt receptor activity. For example, knocking out ROR2 can test whether WNT5a-mediated Hippo pathway activation and YAP1 suppression depend on this receptor. Knockout of SIRT1 can test its role in vitamin D antagonism of Wnt/beta-catenin.
Point Mutation
Point-mutation knock-in can dissect the residues required for ligand binding, receptor activation, or downstream coupling. This is particularly useful for LRP6 and FZD receptors, where specific mutations can separate canonical from non-canonical outputs. Point mutations can also test whether a phosphorylation site on ROR2 is required for Hippo pathway activation.
Knock-in
Knock-in of epitope or fluorescent tags at endogenous FZD or ROR loci enables monitoring of receptor expression, localization, and trafficking without overexpression artifacts. Knock-in of reporter cassettes can also create allele-specific readouts of Wnt receptor activity.
Overexpression
Overexpression of Wnt ligands such as WNT5A or receptors such as FZD7 can activate Wnt receptor activity and downstream outputs. Overexpression of WNT5A in cells with ROR2 can activate the Hippo pathway and suppress YAP1. Overexpression models are useful for gain-of-function studies but should be interpreted with attention to non-physiological levels.
How EDITGENE Supports Wnt receptor activity Research
Researchers studying Wnt receptor activity-related genes often need to determine whether a candidate gene is causally involved in ligand binding, signal transduction, or downstream transcriptional output. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of GO:0042813-related hypotheses, from receptor knockout to point-mutation knock-in and overexpression.
Contact EDITGENE today to design your custom CRISPR model for Wnt receptor activity research.
Frequently Asked Questions About Wnt receptor activity
What is Wnt receptor activity?
Wnt receptor activity (GO:0042813) is a molecular function defined as combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity. It is mediated by receptors such as Frizzled proteins and co-receptors.
What genes are involved in Wnt receptor activity?
Key genes include FZD family receptors, LRP5/LRP6 co-receptors, ROR1/ROR2 receptor tyrosine kinases, and Wnt ligands such as WNT3A and WNT5A.
What is the GO ID for Wnt receptor activity?
The Gene Ontology ID for Wnt receptor activity is GO:0042813, and it belongs to the molecular_function ontology.
How is Wnt receptor activity different from Wnt signaling?
Wnt receptor activity describes the molecular function of binding Wnt and transmitting the signal across the membrane, while Wnt signaling refers to the broader biological process and downstream outputs.
Can Wnt receptor activity activate both canonical and non-canonical pathways?
Yes. In colon cancer cells, canonical and non-canonical Wnt signaling are simultaneously activated by Wnts, indicating that receptor activity can branch into multiple outputs.
Does Wnt receptor activity affect YAP/TAZ?
Yes. Alternative Wnt signaling activates YAP/TAZ, and WNT5a signaling through ROR2 can activate the Hippo pathway to suppress YAP1 activity and tumor growth.
What diseases are linked to Wnt receptor activity?
Wnt receptor activity is linked to cancer, lung physiology and pathology, bone mass regulation, and metabolic signaling.
How do you study Wnt receptor activity in the lab?
Common methods include luciferase reporter assays, CRISPR knockout and point-mutation models, co-immunoprecipitation, live-cell imaging, RNA-seq, and proteomics.
What is the role of SIRT1 in Wnt receptor activity?
SIRT1 mediates the antagonism of the Wnt/beta-catenin pathway by vitamin D in colon carcinoma cells, showing cross-talk between metabolic regulators and canonical Wnt output.
Can CRISPR be used to model Wnt receptor activity?
Yes. CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models are widely used to test the causal roles of Wnt receptors and ligands.
Conclusion
Wnt receptor activity (GO:0042813) is a central molecular function that connects Wnt ligands to diverse downstream outputs, including canonical beta-catenin signaling, non-canonical pathways, and Hippo/YAP/TAZ regulation. Its dysregulation is implicated in cancer, lung pathology, bone mass regulation, and metabolic signaling, making it a high-value target for functional genomics. By combining precise CRISPR models with transcriptional, proteomic, and imaging readouts, researchers can dissect how individual receptors and co-receptors contribute to Wnt receptor activity in health and disease. EDITGENE provides the cell model and screening services needed to generate publication-ready evidence for GO:0042813-related hypotheses.
References
- 1. Flores-Hernández E et al.. 2020. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.. Cell Signal 72:109636 PMID: 32283254
- 2. de Almeida Magalhaes T et al.. 2024. Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens.. Dev Cell 59(2):244-261.e6 PMID: 38154460
- 3. Skronska-Wasek W et al.. 2018. WNT receptor signalling in lung physiology and pathology.. Pharmacol Ther 187:150-166 PMID: 29458107
- 4. Park HW et al.. 2015. Alternative Wnt Signaling Activates YAP/TAZ.. Cell 162(4):780-94 PMID: 26276632
- 5. Guo Y et al.. 2025. Exercise increases bone mass by lactate/Gpr81 signaling pathway.. Commun Biol 8(1):1548 PMID: 41214246
- 6. García-Martínez JM et al.. 2024. SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells.. Int J Biol Sci 20(14):5495-5509 PMID: 39494323
- 7. Stricker S et al.. 2017. ROR-Family Receptor Tyrosine Kinases.. Curr Top Dev Biol 123:105-142 PMID: 28236965
- 8. Wang K et al.. 2023. WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.. Cancer Res 83(7):1016-1030 PMID: 36622276
